GABAB-receptor-mediated suppression of sympathetic outflow from the spinal cord of neonatal rats. 2005

Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.

Using a splanchnic nerve-spinal cord preparation in vitro that could spontaneously generate sympathetic nerve discharge (SND), we investigated the roles of intraspinal GABA(B) receptors in the regulation of SND. Despite an age-dependent difference in sensitivity, bath applications of baclofen (Bac; GABA(B)-receptor agonist) consistently reduced SND in a concentration-dependent manner. The drug specificity of Bac in activation of GABA(B) receptors was verified by application of its antagonist saclofen (Sac) or CGP-46381 (CGP). Sac or CGP alone did not change SND. However, in the presence of Sac or CGP, the effects of Bac on SND inhibition were reversibly attenuated. The splanchnic sympathetic preganglionic neuron (SPN) was recorded by blind whole cell, patch-clamp techniques. We examined Bac effects on electrical membrane properties of SPNs. Applications of Bac reduced excitatory synaptic events, induced membrane hyperpolarizations, and inhibited SPN firing. In the presence of 12 mM Mg2+ or 0.5 microM TTX to block Ca2+- or action potential-dependent synaptic transmissions, applications of Bac induced an outward baseline current that reversed at -29 +/- 6 mV. Because the K+ equilibrium potential in our experimental conditions was -100 mV, the Bac-induced currents could not simply be attributed to an alteration of K+ conductance. On the other hand, applications of Bac to Cs+-loaded SPNs reduced Cd2+-sensitive and high-voltage-activated inward currents, indicating an inhibition of voltage-gated Ca2+ currents. Our results suggest that the activation of intraspinal GABA(B) receptors suppresses SND via a mixture of ion events that may link to a change in Ca2+ conductance.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D009433 Neural Inhibition The function of opposing or restraining the excitation of neurons or their target excitable cells. Inhibition, Neural
D010721 Phosphinic Acids Inorganic or organic derivatives of phosphinic acid, H2PO(OH). They include phosphinates and phosphinic acid esters. Hypophosphorous Acids,Phosphinic Acid,Acid, Phosphinic,Acids, Hypophosphorous,Acids, Phosphinic
D002104 Cadmium An element with atomic symbol Cd, atomic number 48, and atomic weight 112.41. It is a metal and ingestion will lead to CADMIUM POISONING.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002586 Cesium A member of the alkali metals. It has an atomic symbol Cs, atomic number 55, and atomic weight 132.91. Cesium has many industrial applications, including the construction of atomic clocks based on its atomic vibrational frequency. Caesium,Caesium-133,Cesium-133,Caesium 133,Cesium 133
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000831 Animals, Newborn Refers to animals in the period of time just after birth. Animals, Neonatal,Animal, Neonatal,Animal, Newborn,Neonatal Animal,Neonatal Animals,Newborn Animal,Newborn Animals

Related Publications

Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
November 1970, The American journal of physiology,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
April 1996, Brain research,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
August 1993, Neuroscience letters,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
December 1994, British journal of pharmacology,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
January 1987, Synapse (New York, N.Y.),
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
January 1990, Advances in biochemical psychopharmacology,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
December 1994, British journal of pharmacology,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
November 1993, European journal of pharmacology,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
July 2008, American journal of physiology. Regulatory, integrative and comparative physiology,
Yi-Wen Cheng, and Min-Chi Ku, and Chiu-Ming Ho, and Chok-Yung Chai, and Chun-Kuei Su
July 2005, Experimental neurology,
Copied contents to your clipboard!